The AACI Physician Clinical Leadership Initiative (PCLI) will present a webinar on developing and implementing a telemedicine program on Thursday, April 25 at 12:00 pm eastern. Registration is now open.
Moderated by Andrew E. Chapman, DO, FACP, chief of cancer services at the Sidney Kimmel Cancer Center at Jefferson Health (SKCC) and member of the PCLI steering committee, the webinar will address strategies for developing and applying a telemedicine approach to oncology. Dr. Chapman will be joined by his SKCC colleagues, Adam Binder, MD, and Ana María López, MD, MPH, MACP. Dr. Binder will focus on the background and importance of telemedicine. Dr. López will follow with specific approaches and considerations for oncology telemedicine. They will close their presentation with future directions and a Q&A.
Andrew E. Chapman DO, FACP, is a clinical professor in the Department of Medical Oncology of the SKCC and in the Jefferson College of Nursing. Dr. Chapman is the chief of cancer services for the SKCC, enterprise SVP of medical oncology for the Jefferson Health System, and vice chair for clinical operations for the Department of Medical Oncology. Dr. Chapman earned his BS at the University of Pennsylvania and his MD from the University of Health Sciences in Kansas City, Missouri. He joined the medical staff at Thomas Jefferson University Hospital in 1994, including a medical school appointment at Jefferson Medical College. A fellow of the American College of Physicians, Dr. Chapman is board-certified in hematology and medical oncology.
Adam Binder MD, is assistant professor and quality officer for the division of hematologic malignancies at the SKCC. Dr. Binder came to the SKCC from Montefiore Medical Center where he focused his efforts on quality improvement initiatives and hematologic malignancies. His current work focuses on process improvement initiatives, patient safety, and health care innovation. In fellowship, Dr. Binder worked to establish a store and forward telehematology program with small hospitals in sub-Saharan Africa, and at Montefiore he was part of the effort to implement an e-consultative system between primary care physicians and benign hematologists. He also serves on the American Society of Hematology Quality Committee.
Ana María López, MD, MPH, MACP, is vice chair of medical oncology and chief, New Jersey division, at the SKCC. Dr. López is a board-certified medical oncologist who specializes in women’s cancers, integrative oncology, and cancer prevention. She earned her bachelor’s degree from Bryn Mawr College and her MD from Jefferson Medical College of Thomas Jefferson University. Dr. López trained in internal medicine and hematology and oncology and completed a Master of Public Health degree in health policy and administration. Currently serving as president of the American College of Physicians, Dr. López has recognized expertise in health equity, cancer prevention, and telemedicine.